More than 80% of patients with Parkinson's disease (PD) develop dysphagia during the
course of their disease. Swallowing impairment reduces quality of life, complicates …

Abstract Parkinson's disease (PD), a neurodegenerative disorder, is traditionally classified
as a movement disorder. Patients typically suffer from many motor dysfunctions. Presently …

Parkinson's disease (PD) is a neurodegenerative disease caused by the loss of
dopaminergic neurons in the substantia nigra. A characteristic pathological feature of PD is …

Parkinson's disease (PD) is a progressive neurodegenerative disease that leads to a wide
range of motor and nonmotor deficits. Specifically, voice and swallow deficits manifest early …

Abstract Molecular chaperone HSP70 (HSPA1A) has therapeutic potential in conformational
neurological diseases. Here we evaluate the neuroprotective function of the chaperone in a …

Parkinson's disease (PD) is a progressive, degenerative disorder that affects 10 million
people worldwide. More than 90% of individuals with PD develop hypokinetic dysarthria, a …

Parkinson's disease (PD) is a devastating neurodegenerative disease that leads to motor
deficits and selective destruction of nigrostriatal dopaminergic neurons. PD is typically …

Abstract Background Synucleinopathies such as Parkinson's disease or multiple system
atrophy are characterized by Lewy bodies in distinct brain areas. These aggregates are …

Dysphagia is commonly associated with aging and Parkinson disease and can have a
significant impact on a person's quality of life. In some cases, dysphagia may be life …

Parkinson disease (PD) causes voice and swallow dysfunction even in early stages of the
disease. Treatment of this dysfunction is limited, and the neuropathology underlying this …